Aimovig® (erenumab-aooe)
for Migraine

Aimovig (erenumab-aooe) is a once-monthly, self-administered injection used to prevent migraines in adults. It reduces the number of migraine days by blocking calcitonin gene-related peptide (CGRP), a protein that rises during migraine attacks. Aimovig prevents CGRP from binding to its receptor, helping to stop migraines before they start. It is given under the skin using an autoinjector or prefilled syringe and belongs to a class of CGRP inhibitors.

Heart
Medication Guide Icon Medication Guide
TV Commercial Icon TV Commercial
Patient Website Icon Patient Website
Efficacy Data Icon Efficacy Data
New Articles Icon New Articles
Savings and Support Icon Savings and Support
Company MD Payments Icon Company MD Payments
Clinical Trials Icon Clinical Trials
Adverse Event Report Icon Adverse Event Report
Other top medicines used to treat Migraine